Updates in Systemic Therapy for Non-Metastatic Lung Cancer

EP. 1: Treatment of Early-Stage NSCLC: Current Standard of Care

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospitale,Ticiana Leal, MD, University of Wisconsin-Madison,Jarushka Naidoo, MBBCh, Beaumont Hospital,Ravi Salgia, MD, PhD, City of Hope Comprehensive Cancer Center,Jun Zhang, MD, PhD, University of Kansas Medical Center

October 26th 2020

EP. 2: Neoadjuvant Chemotherapy in Early-Stage NSCLC

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospitale,Ticiana Leal, MD, University of Wisconsin-Madison,Jarushka Naidoo, MBBCh, Beaumont Hospital,Ravi Salgia, MD, PhD, City of Hope Comprehensive Cancer Center,Jun Zhang, MD, PhD, University of Kansas Medical Center

October 26th 2020

EP. 3: Role of Postoperative Radiotherapy in Early Stage NSCLC

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospitale,Ticiana Leal, MD, University of Wisconsin-Madison,Jarushka Naidoo, MBBCh, Beaumont Hospital,Ravi Salgia, MD, PhD, City of Hope Comprehensive Cancer Center,Jun Zhang, MD, PhD, University of Kansas Medical Center

October 26th 2020

EP. 4: Phase 3 ADAURA Study: EGFR-Mutated NSCLC

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospitale,Ticiana Leal, MD, University of Wisconsin-Madison,Jarushka Naidoo, MBBCh, Beaumont Hospital,Ravi Salgia, MD, PhD, City of Hope Comprehensive Cancer Center,Jun Zhang, MD, PhD, University of Kansas Medical Center

October 26th 2020

EP. 5: Patient Selection: Adjuvant Therapy and Testing for ES NSCLC

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospitale,Ticiana Leal, MD, University of Wisconsin-Madison,Jarushka Naidoo, MBBCh, Beaumont Hospital,Ravi Salgia, MD, PhD, City of Hope Comprehensive Cancer Center,Jun Zhang, MD, PhD, University of Kansas Medical Center

October 26th 2020

EP. 6: Role of Neoadjuvant I/O in ES NSCLC

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospitale,Ticiana Leal, MD, University of Wisconsin-Madison,Jarushka Naidoo, MBBCh, Beaumont Hospital,Ravi Salgia, MD, PhD, City of Hope Comprehensive Cancer Center,Jun Zhang, MD, PhD, University of Kansas Medical Center

October 26th 2020

EP. 7: Key Trials in Neoadjuvant I/O for ES NSCLC

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospitale,Ticiana Leal, MD, University of Wisconsin-Madison,Jarushka Naidoo, MBBCh, Beaumont Hospital,Ravi Salgia, MD, PhD, City of Hope Comprehensive Cancer Center,Jun Zhang, MD, PhD, University of Kansas Medical Center

October 26th 2020

EP. 8: Neoadjuvant I/O for ES NSCLC: Key Trials from ESMO 2020

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospitale,Ticiana Leal, MD, University of Wisconsin-Madison,Jarushka Naidoo, MBBCh, Beaumont Hospital,Ravi Salgia, MD, PhD, City of Hope Comprehensive Cancer Center,Jun Zhang, MD, PhD, University of Kansas Medical Center

October 26th 2020

EP. 9: Future of Neoadjuvant I/O in ES NSCLC

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospitale,Ticiana Leal, MD, University of Wisconsin-Madison,Jarushka Naidoo, MBBCh, Beaumont Hospital,Ravi Salgia, MD, PhD, City of Hope Comprehensive Cancer Center,Jun Zhang, MD, PhD, University of Kansas Medical Center

October 26th 2020

EP. 10: PACIFIC Trial in Stage 3 NSCLC

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospitale,Ticiana Leal, MD, University of Wisconsin-Madison,Jarushka Naidoo, MBBCh, Beaumont Hospital,Ravi Salgia, MD, PhD, City of Hope Comprehensive Cancer Center,Jun Zhang, MD, PhD, University of Kansas Medical Center

October 26th 2020

EP. 11: Considering PD-L1 and EGFR Status With I/O in Stage 3 NSCLC

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospitale,Ticiana Leal, MD, University of Wisconsin-Madison,Jarushka Naidoo, MBBCh, Beaumont Hospital,Ravi Salgia, MD, PhD, City of Hope Comprehensive Cancer Center,Jun Zhang, MD, PhD, University of Kansas Medical Center

October 26th 2020

EP. 12: Risk of Pneumonitis Post-Chemoradiation in Stage 3 NSCLC

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospitale,Ticiana Leal, MD, University of Wisconsin-Madison,Jarushka Naidoo, MBBCh, Beaumont Hospital,Ravi Salgia, MD, PhD, City of Hope Comprehensive Cancer Center,Jun Zhang, MD, PhD, University of Kansas Medical Center

October 26th 2020

EP. 13: Takeaways on Treatment of Early-Stage NSCLC

ByBenjamin Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospitale,Ticiana Leal, MD, University of Wisconsin-Madison,Jarushka Naidoo, MBBCh, Beaumont Hospital,Ravi Salgia, MD, PhD, City of Hope Comprehensive Cancer Center,Jun Zhang, MD, PhD, University of Kansas Medical Center

October 26th 2020

Episodes

EP. 1: Treatment of Early-Stage NSCLC: Current Standard of Care

EP. 2: Neoadjuvant Chemotherapy in Early-Stage NSCLC

EP. 3: Role of Postoperative Radiotherapy in Early Stage NSCLC

EP. 4: Phase 3 ADAURA Study: EGFR-Mutated NSCLC

EP. 5: Patient Selection: Adjuvant Therapy and Testing for ES NSCLC

EP. 6: Role of Neoadjuvant I/O in ES NSCLC

EP. 7: Key Trials in Neoadjuvant I/O for ES NSCLC

EP. 8: Neoadjuvant I/O for ES NSCLC: Key Trials from ESMO 2020

EP. 9: Future of Neoadjuvant I/O in ES NSCLC

EP. 10: PACIFIC Trial in Stage 3 NSCLC

EP. 11: Considering PD-L1 and EGFR Status With I/O in Stage 3 NSCLC

EP. 12: Risk of Pneumonitis Post-Chemoradiation in Stage 3 NSCLC

EP. 13: Takeaways on Treatment of Early-Stage NSCLC

Trending on OncLive

FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC

FDA Accepts NDA for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer

Dr Patel on the Unmet Need in EGFR+ Transformed Small Cell Lung Cancer

Dr Galsky on Systemic Therapy Advances in Muscle-Invasive Bladder Cancer

Dr Cooper on Biomarker Selection for DLL3-Targeted Therapies in ES-SCLC